SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Terra Tech Corp (OTCMKTS:TRTC) provided an update on the development of IVXX Cannabis Products. It disclosed that the premiere quality cannabis products will now be available in Van Nuys at The KindCenter. It is one of LA’s highly-patient focused dispensaries. They pay utmost attention to testing the products and only keep the highest quality medications for patients.

The acceptance

Derek Peterson, the CEO of Terra Tech, said that the acceptance that the company is witnessing in the LA market has surpassed the expectations. The company is ramping up the production in order to fulfill the increased demand. It has received huge appreciation for the quality and packaging of the products. The patients are delighted with the performance of IVXX brand,

Expansion measures

Terra Tech has been taking several measures to expand its product reach to customers. In recent update, the company’s subsidiary unit Edible Garden disclosed that product range of living produce will be available at additional Wal-Mart Stores, Inc. (NYSE:WMT) distribution centers. It indicates that the company will be able to extend its product reach to another 300 retail stores. The high quality products and consistency helped the company to get the extended benefits.

The expert speaks

Peterson further added that it is a major achievement for Edible Garden brand and increase of confidence in Terra Tech’s abilities to service additional centers in the United States. The management is delighted and encouraged that big retailers are strongly supporting local farmers and investing in local communities. It is also leading to creation of local jobs. The first orders under the new deal are expected to reach the centers by late May.

In last trading session, the share price of Terra Tech declined more than 1% to close the trading session at $0.188. The decline came at a share volume of 449,117 compared to average share volume of 1.42 million.